Vascular Response After Everolimus-Eluting Stent in Acute Myocardial Infarction Caused by Calcified Nodule.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 08 2022
Historique:
pubmed: 12 5 2022
medline: 27 8 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

Patients with acute myocardial infarction (AMI) caused by calcified nodules (CN) have worse clinical outcomes following primary percutaneous coronary intervention (PCI). This study investigated the late vascular response after everolimus-eluting stent (EES) implantation assessed by optical coherence tomography (OCT) in patients with AMI caused by CN, by comparing with plaque rupture (PR) and plaque erosion (PE).Methods and Results: Based on the OCT findings in AMI culprit lesions before PCI, a total of 141 patients were categorized into 3 groups (PR, PE, or CN), and the OCT findings immediately and 10 months after PCI were compared. The frequency of PR, PE, and CN was 85 (60%), 45 (32%), and 11 patients (8%), respectively. In the 10-month follow-up OCT, the frequency of lesions with uncovered struts and lesions with malapposed struts were highest in the CN group, followed by the PR and PE groups (82% vs. 52% vs. 40%, P=0.042 and 73% vs. 26% vs. 16%, P<0.001, respectively). The incidence of intra-stent thrombus, re-appearance of CN within the stent, and target lesion revascularization were higher in the CN group compared with the PR and PE groups (36% vs. 9% vs. 7%, P=0.028; 27% vs. 0% vs. 0%, P<0.001; and 18% vs. 2% vs. 2%, P=0.024, respectively). Late arterial healing response at 10 months after EES implantation in the CN was worse compared with PR and PE in patients with AMI.

Sections du résumé

BACKGROUND
Patients with acute myocardial infarction (AMI) caused by calcified nodules (CN) have worse clinical outcomes following primary percutaneous coronary intervention (PCI). This study investigated the late vascular response after everolimus-eluting stent (EES) implantation assessed by optical coherence tomography (OCT) in patients with AMI caused by CN, by comparing with plaque rupture (PR) and plaque erosion (PE).Methods and Results: Based on the OCT findings in AMI culprit lesions before PCI, a total of 141 patients were categorized into 3 groups (PR, PE, or CN), and the OCT findings immediately and 10 months after PCI were compared. The frequency of PR, PE, and CN was 85 (60%), 45 (32%), and 11 patients (8%), respectively. In the 10-month follow-up OCT, the frequency of lesions with uncovered struts and lesions with malapposed struts were highest in the CN group, followed by the PR and PE groups (82% vs. 52% vs. 40%, P=0.042 and 73% vs. 26% vs. 16%, P<0.001, respectively). The incidence of intra-stent thrombus, re-appearance of CN within the stent, and target lesion revascularization were higher in the CN group compared with the PR and PE groups (36% vs. 9% vs. 7%, P=0.028; 27% vs. 0% vs. 0%, P<0.001; and 18% vs. 2% vs. 2%, P=0.024, respectively).
CONCLUSIONS
Late arterial healing response at 10 months after EES implantation in the CN was worse compared with PR and PE in patients with AMI.

Identifiants

pubmed: 35545551
doi: 10.1253/circj.CJ-21-1059
doi:

Substances chimiques

Everolimus 9HW64Q8G6G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1388-1396

Auteurs

Yasushi Ino (Y)

Department of Cardiovascular Medicine, Wakayama Medical University.

Masahiro Takahata (M)

Department of Cardiovascular Medicine, Wakayama Medical University.

Takashi Kubo (T)

Department of Cardiovascular Medicine, Wakayama Medical University.

Amir Kh M Khalifa (AKM)

Department of Cardiovascular Medicine, Wakayama Medical University.
Department of Cardiovascular Medicine, Assiut University Hospitals.

Keisuke Satogami (K)

Department of Cardiovascular Medicine, Wakayama Medical University.

Kosei Terada (K)

Department of Cardiovascular Medicine, Wakayama Medical University.

Yuichi Ozaki (Y)

Department of Cardiovascular Medicine, Wakayama Medical University.

Yosuke Katayama (Y)

Department of Cardiovascular Medicine, Wakayama Medical University.

Akira Taruya (A)

Department of Cardiovascular Medicine, Wakayama Medical University.

Shingo Ota (S)

Department of Cardiovascular Medicine, Wakayama Medical University.

Teruaki Wada (T)

Department of Cardiovascular Medicine, Wakayama Medical University.

Takashi Tanimoto (T)

Department of Cardiovascular Medicine, Wakayama Medical University.

Yasutsugu Shiono (Y)

Department of Cardiovascular Medicine, Wakayama Medical University.

Manabu Kashiwagi (M)

Department of Cardiovascular Medicine, Wakayama Medical University.

Akio Kuroi (A)

Department of Cardiovascular Medicine, Wakayama Medical University.

Atsushi Tanaka (A)

Department of Cardiovascular Medicine, Wakayama Medical University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH